A disease duration of less than 1 year predicted a greater reduction in anti-CCP antibody titres with conventional treatment [33], suggesting that a study specifically designed to monitor anti-MCV titres in patients with early RA treated with TNF antagonists might be of interest. Here, TNF is linked to rheumatoid arthritis.